Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance
Authors
Keywords
-
Journal
Nature Communications
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-11-25
DOI
10.1038/ncomms9904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can we safely target the WNT pathway?
- (2014) Michael Kahn NATURE REVIEWS DRUG DISCOVERY
- Understanding and Targeting Alkylator Resistance in Glioblastoma
- (2014) W. Wick et al. Cancer Discovery
- A Novel Tankyrase Small-Molecule Inhibitor Suppresses APC Mutation-Driven Colorectal Tumor Growth
- (2013) T. Lau et al. CANCER RESEARCH
- DNA repair mechanisms in dividing and non-dividing cells
- (2013) Teruaki Iyama et al. DNA REPAIR
- DNA double‐strand break response in stem cells: Mechanisms to maintain genomic integrity
- (2012) Pratik Nagaria et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours
- (2012) A O von Bueren et al. BRITISH JOURNAL OF CANCER
- A Novel Tankyrase Inhibitor Decreases Canonical Wnt Signaling in Colon Carcinoma Cells and Reduces Tumor Growth in Conditional APC Mutant Mice
- (2012) J. Waaler et al. CANCER RESEARCH
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells
- (2011) Desheng Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Targeting O 6-methylguanine-DNA methyltransferase with specific inhibitors as a strategy in cancer therapy
- (2010) Bernd Kaina et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- A Two-Step Model for Colon Adenoma Initiation and Progression Caused by APC Loss
- (2009) Reid A. Phelps et al. CELL
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
- (2009) Jennifer A. Quinn et al. JOURNAL OF CLINICAL ONCOLOGY
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
- (2009) Shih-Min A. Huang et al. NATURE
- The fluorometric microculture cytotoxicity assay
- (2008) Elin Lindhagen et al. Nature Protocols
- Tumor-growth–promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets
- (2008) Ninib Baryawno et al. NEURO-ONCOLOGY
- Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
- (2008) Marcel Kool et al. PLoS One
- Dose translation from animal to human studies revisited
- (2007) Shannon Reagan-Shaw et al. FASEB JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now